Except for the one Myc-expressing tumor that also expresses high level LMP1, immunoblot analysis of tumor extracts confirmed that expression of both the full-length and cleaved (activated) forms of the NF-κB2 (p100/52) is much lower in the tumors expressing Myc (Fig 6A). The gene discussed is MYC; the disease is neoplasm.